Search results: Sage Journals

Restricted accessResearch articleFirst published April, 2002

Myeloablative Radioimmunotherapy with Re-188-anti-CD66-Antibody for Conditioning of High-Risk Leukemia Patients Prior to Stem Cell Transplantation: Biodistribution,Biokinetics and Immediate Toxicities

Inga Buchmann, Donald Bunjes, Jörg Kotzerke [...]

Cancer Biotherapy and Radiopharmaceuticals

Restricted accessResearch articleFirst published February, 2002

Dosimetry in a Myeloablative Setting

Hazel Breitz

Cancer Biotherapy and Radiopharmaceuticals

Restricted accessResearch articleFirst published January, 2014

Intestinal response to myeloablative chemotherapy in piglets

Peter L Pontoppidan, René L Shen, Bodil L Petersen [...]

Experimental Biology and Medicine

Open accessResearch articleFirst published 2020

Experiences of allogeneic hematopoietic cell transplantation following non-myeloablative conditioning regimen in severely comorbid patients with myelofibrosis: case series with a patient presenting with extensive extramedullary hematopoiesis

Jae-Ho Yoon, Sung-Soo Park, Gi June Min [...]

Therapeutic Advances in Hematology

Free accessReview articleFirst published June, 2012

Effects of Myeloablation,Peripheral Chimerism,and Whole-Body Irradiation on the Entry of Bone Marrow-Derived Cells into the Brain

Antoine Lampron, Martine Lessard, Serge Rivest

Cell Transplantation

Restricted accessResearch articleFirst published June, 1994

Hematopoietic Stem Cell Autografts in Support of Myeloablative Therapy for Multiple Myeloma*

Bart Barlogie, Sundar Jagannath, David Vesole [...]

Stem Cells and Development

Free accessResearch articleFirst published April, 2012

Efficacy of repeat myeloablative chemotherapy with autologous stem-cell support in multiple myeloma

Helge Menzel, Katarzyna Hinmüller, Hans-Jochem Kolb [...]

Therapeutic Advances in Hematology

Restricted accessCase reportFirst published February, 2001

Idiopathic Pneumonia Syndrome following Myeloablative Chemotherapy and Autologous Transplantation

Syed FA Bilgrami, Mark L Metersky, Daniel McNally [...]

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published September, 2019

A unique schedule of palonosetron,ondansetron,and dexamethasone for the prevention of delayed nausea and vomiting in patients receiving myeloablative chemotherapy

J LaPorte, K Leone, X Zhang [...]

Journal of Oncology Pharmacy Practice

Restricted accessReview articleFirst published December, 2022

Myeloablative Conditioning for Transplantation Induces State of Sterile Inflammation in the Bone Marrow: Implications for Optimizing Homing and Engraftment of Hematopoietic Stem Cells

Mariusz Z. Ratajczak, Mateusz Adamiak, Andrzej Deptała [...]

Antioxidants & Redox Signaling

Restricted accessResearch articleFirst published April, 2002

Myeloablative Radioimmunotherapy with Re-188-anti-CD66-Antibody for Conditioning of High-Risk Leukemia Patients Prior to Stem Cell Transplantation: Biodistribution,Biokinetics and Immediate Toxicities

Inga Buchmann, Donald Bunjes, Jörg Kotzerke [...]

Cancer Biotherapy and Radiopharmaceuticals

Restricted accessResearch articleFirst published February, 2002

Dosimetry in a Myeloablative Setting

Hazel Breitz

Cancer Biotherapy and Radiopharmaceuticals

Restricted accessResearch articleFirst published January, 2014

Intestinal response to myeloablative chemotherapy in piglets

Peter L Pontoppidan, René L Shen, Bodil L Petersen [...]

Experimental Biology and Medicine

Open accessResearch articleFirst published 2020

Experiences of allogeneic hematopoietic cell transplantation following non-myeloablative conditioning regimen in severely comorbid patients with myelofibrosis: case series with a patient presenting with extensive extramedullary hematopoiesis

Jae-Ho Yoon, Sung-Soo Park, Gi June Min [...]

Therapeutic Advances in Hematology

Free accessReview articleFirst published June, 2012

Effects of Myeloablation,Peripheral Chimerism,and Whole-Body Irradiation on the Entry of Bone Marrow-Derived Cells into the Brain

Antoine Lampron, Martine Lessard, Serge Rivest

Cell Transplantation

Restricted accessResearch articleFirst published June, 1994

Hematopoietic Stem Cell Autografts in Support of Myeloablative Therapy for Multiple Myeloma*

Bart Barlogie, Sundar Jagannath, David Vesole [...]

Stem Cells and Development

Free accessResearch articleFirst published April, 2012

Efficacy of repeat myeloablative chemotherapy with autologous stem-cell support in multiple myeloma

Helge Menzel, Katarzyna Hinmüller, Hans-Jochem Kolb [...]

Therapeutic Advances in Hematology

Restricted accessCase reportFirst published February, 2001

Idiopathic Pneumonia Syndrome following Myeloablative Chemotherapy and Autologous Transplantation

Syed FA Bilgrami, Mark L Metersky, Daniel McNally [...]

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published September, 2019

A unique schedule of palonosetron,ondansetron,and dexamethasone for the prevention of delayed nausea and vomiting in patients receiving myeloablative chemotherapy

J LaPorte, K Leone, X Zhang [...]

Journal of Oncology Pharmacy Practice

Restricted accessReview articleFirst published December, 2022

Myeloablative Conditioning for Transplantation Induces State of Sterile Inflammation in the Bone Marrow: Implications for Optimizing Homing and Engraftment of Hematopoietic Stem Cells

Mariusz Z. Ratajczak, Mateusz Adamiak, Andrzej Deptała [...]

Antioxidants & Redox Signaling